Ofloxacin 0.3% Eye DropsThird Party Manufacturing in India

Ofloxacin is a synthetic broad-spectrum fluoroquinolone antibiotic that kills bacteria by inhibiting two essential enzymes: DNA gyrase and topoisomerase IV. By binding to these enzymes, ofloxacin prevents the uncoiling and replication of bacterial DNA, leading to irreversible damage and cell death. This dual mechanism reduces the likelihood of bacterial resistance development. Ofloxacin demonstrates bactericidal activity against a wide range of gram-positive and gram-negative aerobic bacteria, including Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeruginosa, Escherichia coli, and Haemophilus influenzae. Its favorable pharmacokinetic profile includes good penetration into the corneal stroma and aqueous humor following topical administration, achieving therapeutic concentrations in ocular tissues.

Therapeutic Uses

Ofloxacin 0.3% Eye Drops are prescribed for:

• Bacterial Conjunctivitis: Acute and chronic conjunctivitis caused by susceptible bacterial strains.
• Bacterial Keratitis: Corneal infections requiring prompt broad-spectrum antibiotic therapy.
• Blepharitis: Infection of the eyelid margins with associated inflammation.
• Pre- and Post-Operative Prophylaxis: Prevention of infection before and after ophthalmic surgery.
• Corneal Ulcers: Bacterial corneal ulcers where prompt, effective antibiotic coverage is needed.

Why Manufacturers Choose Ofloxacin

Ofloxacin 0.3% eye drops are one of the most widely prescribed ophthalmic antibiotics in India, available in 5ml and 10ml packs. It is a versatile, high-volume product with strong demand from ophthalmology clinics, hospitals, and the PCD franchise network. Ofloxacin third party manufacturing in India represents a reliable revenue stream for manufacturers, with extensive export potential to Africa, Southeast Asia, and the Middle East.